02/26/13 - 11:00 AM EST
Options expert Tony Pelz says options are the best way to trade Ziopharma's looming palifosamide data.
02/12/13 - 08:30 AM EST
Options expert Tony Pelz offers investors a way to use options to trade Dynavax's upcoming FDA decision.
12/12/12 - 11:27 AM EST
A new options trade for Alexza going into an FDA drug approval decision.
12/04/12 - 09:05 AM EST
Contributor Tony Pelz offers an options trade for those who believe Amicus shares are going higher.
11/20/12 - 07:31 AM EST
How to use options to play a possible run-up in Dynavax prior to the FDA's approval decision.
11/06/12 - 08:00 AM EST
Options wizard Tony Pelz suggests another way to trade Exelixis's FDA drug approval decision.
11/01/12 - 10:01 AM EDT
Tony Pelz offers a short-term options trade to take advantage of end-of-year selling in Eli Lilly.
10/22/12 - 08:30 AM EDT
How to play the high-risk release of results from Ziopharm's phase III study.
10/15/12 - 09:00 AM EDT
Options guru Tony Pelz offers options trades for those who want to protect their Sarepta profits.
10/08/12 - 08:00 AM EDT
Biotech options expert Tony Pelz recommends a bullish options trade for the Oct. 16 Gattex FDA panel.